08 Jan 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf
16 Dec 2024
// FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gnmart-inc-issues-voluntary-nationwide-recall-force-forever-due-undeclared-drug-ingredients
11 Dec 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2024-90405.pdf
21 Nov 2024
// FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mxbbb-issues-voluntary-nationwide-recall-umary-acid-hyaluronic-due-presence-diclofenac-and
20 Nov 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-20-2024-11761.pdf
06 Nov 2024
// FDA
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vitalityvita-issues-voluntary-nationwide-recall-vitalityxtra-and-peakmax-capsules-due-presence